CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
Authors:
- 5 April 2007
- journal article
- Published by Springer Nature in Leukemia
- Vol. 21 (6) , 1249-1257
Abstract
The role of CXCL12 in the bone marrow (BM) homing and growth of B-cell progenitor acute lymphoblastic leukemia (ALL) has been established. However, the effect of modulating CXCL12/CXCR4 interactions on the retention of ALL cells within the supportive BM microenvironment and the expansion and dissemination of ALL cells in vivo has not been examined. We used mouse models of human childhood and murine leukemia and specific peptide and small molecule CXCR4 antagonists to examine the importance of CXCL12/CXCR4 in the development of leukemia in vivo. CXCR4 antagonists mobilized ALL cells into the peripheral blood (PB). Extended administration of CXCR4 antagonists to mice with leukemia resulted in a reduction in the number of leukemic cells in the PB and spleens of animals compared to control treated animals in three of the five cases tested. There was also a marked reduction in the dissemination of ALL cells to extramedullary sites including liver and kidney in all cases where this occurred. Considering the inhibitory effect of stromal layers on the activity of chemotherapeutic agents and the interactive effect of CXCL12 antagonists with chemotherapeutic agents in vitro, this raises the possibility of using these agents to potentiate the effects of current chemotherapy regimens.Keywords
This publication has 36 references indexed in Scilit:
- Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4–/– chimeric miceBlood, 2006
- CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood, 2006
- Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26Science, 2004
- A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanomaBiochemical and Biophysical Research Communications, 2004
- Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistBlood, 2003
- Childhood acute lymphoblastic leukemiaReviews in Clinical and Experimental Hematology, 2002
- Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell functionJournal of Clinical Investigation, 2000
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996
- Interaction of Acute Leukemia Cells with the Bone Marrow Microenvironment: Implications for Control of Minimal Residual DiseaseLeukemia & Lymphoma, 1995